This page was automatically translated and may contain errors. View in English.
N

Executive Director, Asset Project Leadership

Necessary Ventures

New York, United States · Tempo pieno

Sii il primo a candidarti

Esperienza
10+ anni
Stipendio
USD 297,000 – USD 356,400 / year
Aperture
1
Pubblicato
1 ora fa
Modalità di lavoro
In ufficio
Istruzione
PhD in life sciences or related scientific discipline
Requisiti di ammissibilità
Qualified candidates with requisite scientific and industry experience meeting the specified educational and experiential criteria.
Riprendere
È necessario candidarsi

Dove lavorerai

Descrizione del lavoro

About the Role

Join Recursion as the Executive Director of Asset Project Leadership in New York, NY, where your contributions will deeply impact lives including your own. This role is central to integrating cutting-edge computational methods and Recursion's proprietary technologies across drug development stages, reshaping traditional approaches to medicine development.

Key Responsibilities

  • Collaborate closely with functional leaders across the portfolio to ensure coherent, data-driven strategies from early discovery through clinical phases.
  • Cultivate a culture emphasizing responsibility, innovation, and dedication to bringing essential medicines to patients.
  • Coordinate with stakeholders in finance and operational leadership to prioritize and allocate resources effectively for high-impact projects.
  • Develop and enhance processes that fully utilize Recursion OS and ClinTech insights to advance internal and partnered drug discovery and development initiatives.
  • Promote a transformative mindset seeking continual improvement in progressing innovative therapeutic concepts for clinical use.

Team and Environment

You will be part of the Development team led by the Global Head of Project Leadership. This group focuses on translating Recursion's scientific innovations into patient therapies by leveraging state-of-the-art clinical technologies including AI-driven platforms, real-world evidence, and biomarker tools.

Qualifications

  • PhD in life sciences or a related scientific field with significant experience in drug discovery and development.
  • Over 10 years of experience in the biotech or pharmaceutical sector with demonstrated leadership in advancing drug development programs using data-driven decision-making.
  • Proven expertise in cross-functional drug development processes and applying computational techniques to optimize therapeutic assets.
  • Strong knowledge in oncology is essential; additional expertise in rare diseases or immunology/inflammation is advantageous.
  • Sound financial and resource management skills.

Work Location and Compensation

This position is hybrid with a requirement for at least 50% onsite presence in Recursion's New York office. The salary range is estimated between $297,000 and $356,400 annually, supplemented by performance bonuses, equity, and comprehensive benefits.

Core Values

  • Act boldly yet ethically to push boundaries and inspire innovation.
  • Engage with care and direct communication fostering responsibility and respect.
  • Adapt quickly through active learning and iterative progress.
  • Maintain urgency in delivering results due to patient needs.
  • Embrace ownership and accountability for individual and team outcomes.
  • Promote collaborative cross-functional teamwork to maximize impact.

Additional Information

Recursion is a clinical-stage TechBio company using artificial intelligence and scientific innovation to revolutionize drug development. The organization is committed to equal employment opportunities and accommodations during the recruitment process. Recruitment agencies should note that unsolicited resumes will not be accepted.

Lasciate questo messaggio se desiderate una risposta: non lo useremo per nessun altro scopo.

Clicca per navigare, trascina e rilascia, oppure impasto uno screenshot

PNG, JPG, GIF, MP4, WebM, MOV · Dimensione massima 20 MB ciascuno · Fino a 5 file

🤖
Assistenza online tramite intelligenza artificiale immediata